D. Cittelly

发表

Estradiol induces BDNF/TrkB signaling in triple-negative breast cancer to promote brain metastases

P. Steeg, M. J. Contreras-Zarate, Nicole L. Day, 2019, Oncogene.

Role of the androgen receptor in breast cancer and preclinical analysis of enzalutamide

A. Thor, B. Jacobsen, D. Cittelly, 2014, Breast Cancer Research.

Downregulation of miR-342 is associated with tamoxifen resistant breast tumors

P. M. Das, A. Thor, D. Cittelly, 2010, Molecular Cancer.

Altered MicroRNA Activity Promotes Resistance to Endocrine Therapy

D. Cittelly, 2009 .

Exogenous Bcl‐xl fusion protein spares neurons after spinal cord injury

C. Hulsebosch, D. McAdoo, K. Westlund, 2005, Journal of neuroscience research.

Progestin suppression of miR-29 potentiates dedifferentiation of breast cancer cells via KLF4

B. Jacobsen, C. Sartorius, D. Cittelly, 2013, Oncogene.

Steroid receptors and microRNAs: Relationships revealed

D. Cittelly, D. Cochrane, J. Richer, 2011, Steroids.

Fibroblast Subtypes Regulate Responsiveness of Luminal Breast Cancer to Estrogen

Austin E. Gillen, A. Tan, P. Kabos, 2016, Clinical Cancer Research.

Phosphorylation of Bcl‐xL after spinal cord injury

J. Perez-polo, D. Cittelly, O. Nesic-Taylor, 2007, Journal of neuroscience research.

Sex steroid hormone function in the brain niche: Implications for brain metastatic colonization and progression

M. J. Contreras-Zarate, D. Cittelly, M. Contreras-Zarate, 2020, Cancer reports.

Fibroblast subtypes define a metastatic matrisome in breast cancer.

Austin E. Gillen, K. Horwitz, P. Kabos, 2020, JCI insight.

Estrogen promotes the brain metastatic colonization of triple negative breast cancer cells via an astrocyte-mediated paracrine mechanism

P. Steeg, N. Serkova, P. Kabos, 2015, Oncogene.

Brain Metastasis Cell Lines Panel: A Public Resource of Organotropic Cell Lines

A. Bairoch, R. Jain, Paula D. Bos, 2020, Cancer Research.

Detrimental effects of anti-apoptotic treatments in spinal cord injury

C. Hulsebosch, Kathia M. Johnson, D. Cittelly, 2011 .

Detrimental effects of antiapoptotic treatments in spinal cord injury

C. Hulsebosch, J. Perez-polo, Kathia M. Johnson, 2008, Experimental Neurology.

Clinical presentation in relation to diversity within the Helicobacter pylori cag pathogenicity island

D. Graham, Y. Yamaoka, D. Cittelly, 2002, American Journal of Gastroenterology.

Labeling of Breast Cancer Patient-derived Xenografts with Traceable Reporters for Tumor Growth and Metastasis Studies.

C. Sartorius, D. Cittelly, Letty W. Kwok, 2016, Journal of visualized experiments : JoVE.

miR-200c Targets a NF-κB Up-Regulated TrkB/NTF3 Autocrine Signaling Loop to Enhance Anoikis Sensitivity in Triple Negative Breast Cancer

D. Cittelly, E. Howe, D. Cochrane, 2012, PloS one.

IL13Rα2 Promotes Proliferation and Outgrowth of Breast Cancer Brain Metastases

J. Costello, S. Karam, P. Kabos, 2021, Clinical Cancer Research.

MicroRNAs Link Estrogen Receptor Alpha Status and Dicer Levels in Breast Cancer

D. Yee, D. Cittelly, A. Elias, 2010, Hormones & cancer.

Short-term Topiramate treatment prevents radiation-induced cytotoxic edema in preclinical models of breast-cancer brain metastasis

S. Karam, P. Kabos, D. Ormond, 2023, bioRxiv.

Restoration of miR-200c to Ovarian Cancer Reduces Tumor Burden and Increases Sensitivity to Paclitaxel

R. Broaddus, M. Spillman, D. Cittelly, 2012, Molecular Cancer Therapeutics.

Therapeutic Discovery Restoration of miR-200 c to Ovarian Cancer Reduces Tumor Burden and Increases Sensitivity to Paclitaxel

R. Broaddus, M. Spillman, D. Cittelly, 2012 .

Progesterone downregulation of miR-141 contributes to expansion of stem-like breast cancer cells through maintenance of progesterone receptor and Stat5a

B. Jacobsen, P. Kabos, C. Sartorius, 2014, Oncogene.

Activation of Wnt signaling promotes olaparib resistant ovarian cancer

Benjamin G. Bitler, M. Sikora, Elmar Nurmemmedov, 2019, Molecular carcinogenesis.

Development of Novel Patient-Derived Xenografts from Breast Cancer Brain Metastases

Austin E. Gillen, A. Thor, B. Jacobsen, 2017, Front. Oncol..

The effects of ephrinB2 signaling on proliferation and invasion in glioblastoma multiforme.

S. Karam, D. Cittelly, R. Vibhakar, 2020, Molecular carcinogenesis.

Targeting Wnt Signaling To Overcome PARP Inhibitor Resistance

M. Sikora, Elmar Nurmemmedov, K. Behbakht, 2018, bioRxiv.

Reversal of Triple-Negative Breast Cancer EMT by miR-200c Decreases Tryptophan Catabolism and a Program of Immunosuppression

A. Tan, A. D’Alessandro, D. Cittelly, 2018, Molecular Cancer Research.

Oncogenic HER2Δ16 suppresses miR-15a/16 and deregulates BCL-2 to promote endocrine resistance of breast tumors

D. Cittelly, M. Burow, F. Jones, 2010, Carcinogenesis.

Ovarian steroid hormones: what's hot in the stem cell pool?

C. Sartorius, D. Cittelly, J. Richer, 2010, Breast Cancer Research.

Combination of Trastuzumab Emtansine and Stereotactic Radiosurgery Results in High Rates of Clinically Significant Radionecrosis and Dysregulation of Aquaporin-4

L. Gaspar, B. Kavanagh, P. Kabos, 2019, Clinical Cancer Research.

Dicer expression in estrogen receptor-positive versus triple-negative breast cancer: an antibody comparison.

D. Cittelly, A. Elias, Jessica L. Christenson, 2016, Human pathology.

Antiapoptotic therapies in the treatment of spinal cord injury

D. Cittelly, J. Perez-Polo, 2007 .

Breast cancer brain metastases localization and risk of hydrocephalus: a single institution experience

P. Kabos, D. Ormond, D. Cittelly, 2023, Journal of Neuro-Oncology.

Activation of Wnt signaling promotes olaparib resistant ovarian cancer.

Benjamin G. Bitler, M. Sikora, Elmar Nurmemmedov, 2019, Molecular Carcinogenesis.

[Helicobacter pylori genotypes in non atrophic gastritis are different of the found in peptic ulcer, premalignant lesions and gastric cancer in Colombia].

D. Cittelly, M. Bravo, H. Posso, 2002, Revista medica de Chile.

Benjamin G. Bitler, Elmar Nurmemmedov, K. Behbakht, 2019 .

Restoration of miR-200c to Ovarian Cancer Reduces Tumor Burden and Increases Sensitivity to Paclitaxel

R. Broaddus, M. Spillman, D. Cittelly, 2012, Molecular Cancer Therapeutics.